Novo Nordisk A/S Inks Deal Worth up to $100 Million for Heparosan Drug Delivery Platform

Oklahoma City, OK and Austin, TX -- May 1, 2012 -- Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered i…
Read the full story: BioSpace.com Featured News